PTCommunity News March 2016

Dupilumab Shows Promise for Treatment of Atopic Dermatitis
CDC Report: Autism Rate Holds Steady in U.S.
RA Drug Baricitinib Succeeds in Late-Stage Trial
Another Study Confirms Link Between Zika Virus and Fetal Brain Damage
FDA Says “Yes” to Defibrotide (Defitelio) for Hepatic Veno-Occlusive Disease Following Stem-Cell Transplantation
Study: Extended-Release Naltrexone for Opioid Addiction Reduces Risk of Relapse
Diabetes Drug Pioglitazone Linked to Bladder Cancer Risk
To Reduce Addiction, New Jersey Hospitals Try Non-Narcotic Treatment Protocol
FDA Panel Backs Pimavanserin (Nuplazid) for Parkinson’s Psychosis
New Guidelines on Blood-Thinning Therapy
FDA Gives “Thumbs Down” to Calcifediol (Rayaldee) for Hyperparathyroidism
Gene Transfer Shows Promise in Heart Failure Trial
Survey: Pain Patients Give Hospitals Low Marks
Quality-of-Life Data Added to Stiolto Respimat Label
Mount Sinai Assesses Accuracy of Commercially Available Lab Tests
FDA Declines to Expand Label for Antidepressant Drug Vortioxetine (Brintellix)
Malarial Organisms Traced to Age of Dinosaurs
FDA Says “No” to Orphan Drug Status for Blood Cancer Treatment Bendeka
Migraine Treatment Succeeds in Mid-Stage Trial
U.S. Attorney Seeks Records of Novartis “Sham” Events for Doctors
Pharma Company Hikes Price on Aid-in-Dying Drug
CDC Updates Recommendations Related to Zika Virus
Analysts See Seven Potential Blockbuster Drugs Headed to Market in 2016
Help May Be on the Way for Ailing Rural Hospitals
Report: Sickle Cell Care Is Hard to Find for Adults
FDA Issues Guidance for Development of Abuse-Deterrent Opioids
Treatment With Anticoagulant Drug Betrixaban Shows Mixed Results in Phase 3 Trial
Hackers Seek Ransom From Two More California Hospitals
NIH Reviews Status of TB Diagnosis and Treatment
FDA Approves Reslizumab (Cinqair) to Treat Severe Asthma
Alirocumab (Praluent) Succeeds in Cholesterol Study
Certolizumab Pegol (Cimzia) Equivalent to Adalimumab (Humira) in Head-to-Head Comparison
New Guideline for Survivors of Head-and-Neck Cancer
Yale Study: Pulmonary Embolism Treatment Widely Used Despite High Cost and Uncertain Benefit
Ticagrelor (Brilinta) Flops in Key Stroke Trial
FDA Strengthens Warnings for Immediate-Release Opioid Pain Medications
Biotech Med Ixekizumab (Taltz) Wins FDA Nod for Treatment of Plaque Psoriasis
Duchenne Experts Encourage FDA to Approve Eteplirsen
First Time in U.S.: Mount Sinai Treats Liver Cancer With Radiopaque Beads
Study: CABG Prices Vary Widely Among U.S. Hospitals
Unravelling the Secret of Antibiotic Resistance
Human Reovirus Shows Mixed Results as Ovarian Cancer Treatment
FDA Rejects Blood Thinner Bivalirudin (Kangio)
Tofacitinib (Xeljanz) Succeeds in Ulcerative Colitis Trials
30-Year Alzheimer’s Quest May Soon Bear Fruit
FDA Proposes Ban on Most Powdered Medical Gloves
Positive Results Reported From Late-Stage Study of Romosozumab in Men With Osteoporosis
Antibiotics Versus Surgery for Appendicitis
Gene Identified as a Cause and Early Indicator of Breast Cancer
New Possible Candidates for Listeria Infection
Ustekinumab Demonstrates Clinical Response, Remission in Crohn's Disease
Researchers Identify Molecule Needed for Sperm Activation
Potential Zika Virus Risk Estimated for 50 U.S. Cities
Takeda Dumps Obesity Drug Contrave (Naltrexone/Bupropion)
Study: One in Four Seniors Carries ‘Superbugs’ From Hospitals to Post-Acute Care Settings
FDA Approves New Hemophilia Therapy
Scientists Discover Nonopioid Pain Pathway in the Brain
Senate Committee Investigates Concurrent Surgeries
Hospital Pharmacists Pitch In to Improve Care While Keeping Costs Down
Report: Using Generic Cancer Drug Could Save Millions of Dollars
New SARS-Like Virus Is Poised to Infect Humans
CDC Issues Guideline for Prescribing Opioids for Chronic Pain
Hospitals Get Creative as Drug Prices Jump
Atezolizumab Wins Priority Review Designation for Urothelial Carcinoma
Study: Heart Failure Drug Could Provide New Treatment for Herpesvirus Infections
Cytarabine/Daunorubicin Liposome Injection (Vyxeos) Shows Promise in Leukemia Study
New Blood Test for Alzheimer’s Diagnosis
Nine Ways EDs Can Curb the Opioid Epidemic
Survey: Most Hospitals Unprepared for Orthopedic Bundled Payments
Death, Adverse Events Reported in Patients Taking Idelalisib (Zydelig) With Other Drugs
FDA Expands Label for Crizotinib (Xalkori) to Include ROS1-Positive Lung Cancer
Cannabis Drug Succeeds in Epilepsy Trial
Hospital Closures Rattle Small Towns
FDA Panel Reschedules Review of Troubled Muscular Dystrophy Drug Eteplirsen
FDA Finds Anti-Zika Mosquito Environmentally Safe
Study: Sarilumab Superior to Adalimumab in Patients With Active RA
FDA Accepts Application for Expanded Use of Etanercept (Enbrel) to Treat Pediatric Patients With Plaque Psoriasis
Value-Based Care Slashes Health System Profits
Report: High Doses of Experimental Drug Caused Brain Damage in Botched French Trial
Study: Sorafenib and Sunitinib Can’t Stop Cancer Recurrence
Positive Results Reported for Ixmyelocel-T in Heart Failure Trial
New Molecules Help Beta-Lactam Drugs Kill Resistant Bacteria
FDA Lifts Partial Clinical Hold on Pidilizumab
WHO Says Zika Vaccine Trials May Come Too Late
Medicare to Test New Payment Approaches for Prescription Drugs
FDA Clears First Test for Detection of Carbapenem Resistance Genes in “Superbugs”
Task Force Issues Draft Recommendation Statement on Screening for Latent TB Infection in Adults
Zika Linked to Paralyzing Myelitis
Study: Retail Clinics Hike Health Care Costs
New Osteoporosis Treatments on the Horizon
International Consortium Selects ICON to Help Advance Value-Based Health Care
Docs Keep Overprescribing Addictive Drugs Despite Advisory Letter
Predicting Avoidable 30-Day Readmissions
FDA Approves Hemophilia B Therapy Idelvion
Long-Term Study Supports Safety of Asthma Drug Mepolizumab (Nucala)
Celldex Cancels Brain Vaccine Study
Ixekizumab Helps Psoriasis Patients Who Did Not Respond to Etanercept
Liraglutide (Victoza) Lowers Heart Risks in Diabetes Patients
NIH: Marijuana Use Disorder Is Common and Often Untreated
White House Plans Zika Summit
Another Common Mosquito May Carry Zika Virus, Scientists Say
CDC Report: “Superbugs” Threaten Hospital Patients
Study: PQI Tool Is Unable to Identify Preventable Hospital Admissions
Google Works With UNICEF to Map Spread of Zika Virus
FDA Approves New Indication for Breast Cancer Drug Fulvestrant (Faslodex)
FDA Sets Deadline for Review of Extended-Release Granisetron (Sustol)
Snake Venom for Alzheimer’s Disease?
Study: Wasteful Use of Cancer Drugs Costs $3 Billion a Year
FDA Issues New Guideline to Reduce Risk of Zika Virus Transmission by Human Cell and Tissue Products
FDA Approves Single-Tablet Regimen Odefsey for Treatment of HIV-1 Infection
Subcutaneous Ceftriaxone Shows Promise for Treatment of Bacterial Infections
Amgen Submits Supplemental Biologics License Application for Blinatumomab (Blincyto)
Female Libido Drug Flibanserin Gets Mixed Reviews
Report: Half of U.S. Adults Have Musculoskeletal Conditions
Positive Results Reported for Low-Dose, Extended-Release Aspirin (Durlaza)
As ER Docs Adapt to EHRs, Concerns Emerge About Medical Errors
French Scientists Confirm Link Between Zika Virus and Guillain-Barré Syndrome
Clinical Study To Proceed With Oral Formulation of Telintra in Patients With Myelodysplastic Syndrome
‘Masked’ Hypertension Poses Hidden Hazard
Fast Track Designation Granted for Panitumumab
Phase 2 Trial of Hematide To Determine Safety, Pharmacodynamics, and Pharmacokinetics

You are here

PTCommunity News March 2016